These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35430766)

  • 1. Robust delivery of RIG-I agonists using extracellular vesicles for anti-cancer immunotherapy.
    Peng B; Nguyen TM; Jayasinghe MK; Gao C; Pham TT; Vu LT; Yeo EYM; Yap G; Wang L; Goh BC; Tam WL; Luo D; Le MT
    J Extracell Vesicles; 2022 Apr; 11(4):e12187. PubMed ID: 35430766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast-targeted delivery of anti-miRNA oligonucleotides by red blood cell extracellular vesicles.
    Xu L; Xu X; Liang Y; Wen C; Ouyang K; Huang J; Xiao Y; Deng X; Xia J; Duan L
    J Control Release; 2023 Jun; 358():259-272. PubMed ID: 37121514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy.
    Heidegger S; Stritzke F; Dahl S; Daßler-Plenker J; Joachim L; Buschmann D; Fan K; Sauer CM; Ludwig N; Winter C; Enssle S; Li S; Perl M; Görgens A; Haas T; Orberg ET; Göttert S; Wölfel C; Engleitner T; Cortés-Ciriano I; Rad R; Herr W; Giebel B; Ruland J; Bassermann F; Coch C; Hartmann G; Poeck H
    Cell Rep Med; 2023 Sep; 4(9):101171. PubMed ID: 37657445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules.
    Biagiotti S; Canonico B; Tiboni M; Abbas F; Perla E; Montanari M; Battistelli M; Papa S; Casettari L; Rossi L; Guescini M; Magnani M
    Sci Rep; 2024 Jun; 14(1):14610. PubMed ID: 38918594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of 5'-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy.
    Jacobson ME; Wang-Bishop L; Becker KW; Wilson JT
    Biomater Sci; 2019 Jan; 7(2):547-559. PubMed ID: 30379158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.
    Wang-Bishop L; Wehbe M; Pastora LE; Yang J; Kimmel BR; Garland KM; Becker KW; Carson CS; Roth EW; Gibson-Corley KN; Ulkoski D; Krishnamurthy V; Fedorova O; Richmond A; Pyle AM; Wilson JT
    ACS Nano; 2024 May; 18(18):11631-11643. PubMed ID: 38652829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy.
    Helms MW; Jahn-Hofmann K; Gnerlich F; Metz-Weidmann C; Braun M; Dietert G; Scherer P; Grandien K; Theilhaber J; Cao H; Wagenaar TR; Schnurr MM; Endres S; Wiederschain D; Scheidler S; Rothenfußer S; Brunner B; König LM
    Mol Cancer Ther; 2019 Dec; 18(12):2343-2356. PubMed ID: 31515294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade.
    Heidegger S; Kreppel D; Bscheider M; Stritzke F; Nedelko T; Wintges A; Bek S; Fischer JC; Graalmann T; Kalinke U; Bassermann F; Haas T; Poeck H
    EBioMedicine; 2019 Mar; 41():146-155. PubMed ID: 30852164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b.
    Vu LT; Peng B; Zhang DX; Ma V; Mathey-Andrews CA; Lam CK; Kiomourtzis T; Jin J; McReynolds L; Huang L; Grimson A; Cho WC; Lieberman J; Le MT
    J Extracell Vesicles; 2019; 8(1):1599680. PubMed ID: 31044053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-triphosphate siRNA targeting HBx elicits a potent anti-HBV immune response in pAAV-HBV transfected mice.
    Han Q; Hou Z; Yin C; Zhang C; Zhang J
    Antiviral Res; 2019 Jan; 161():36-45. PubMed ID: 30448255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy.
    Thangaraju K; Neerukonda SN; Katneni U; Buehler PW
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy.
    Hansen AS; Jensen LS; Gammelgaard KR; Ryttersgaard KG; Krapp C; Just J; Jønsson KL; Jensen PB; Boesen T; Johansen M; Etzerodt A; Deleuran BW; Jakobsen MR
    J Extracell Vesicles; 2023 Aug; 12(8):e12350. PubMed ID: 37525396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers.
    Elion DL; Jacobson ME; Hicks DJ; Rahman B; Sanchez V; Gonzales-Ericsson PI; Fedorova O; Pyle AM; Wilson JT; Cook RS
    Cancer Res; 2018 Nov; 78(21):6183-6195. PubMed ID: 30224377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles and Applications of Red Blood Cell-Derived Extracellular Vesicles in Health and Diseases.
    Yang L; Huang S; Zhang Z; Liu Z; Zhang L
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.
    Baldari S; Di Rocco G; Magenta A; Picozza M; Toietta G
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity.
    Thier B; Zhao F; Stupia S; Brüggemann A; Koch J; Schulze N; Horn S; Coch C; Hartmann G; Sucker A; Schadendorf D; Paschen A
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35697379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosomal escape of nucleic acids from extracellular vesicles mediates functional therapeutic delivery.
    Pham TT; Chen H; Nguyen PHD; Jayasinghe MK; Le AH; Le MT
    Pharmacol Res; 2023 Feb; 188():106665. PubMed ID: 36657503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIG-I activation induces the release of extracellular vesicles with antitumor activity.
    Daßler-Plenker J; Reiners KS; van den Boorn JG; Hansen HP; Putschli B; Barnert S; Schuberth-Wagner C; Schubert R; Tüting T; Hallek M; Schlee M; Hartmann G; Pogge von Strandmann E; Coch C
    Oncoimmunology; 2016; 5(10):e1219827. PubMed ID: 27853642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. uPAR
    Porcelli L; Guida M; De Summa S; Di Fonte R; De Risi I; Garofoli M; Caputo M; Negri A; Strippoli S; Serratì S; Azzariti A
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33972390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
    Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.